LTGO
Latigo Biotherapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$23.04
+2.49%Latest reported
- Last report date
- Sep 3, 2026
- EPS actual
- -$0.56
- EPS estimate
- -$0.56
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 3, 2026